Loading…
Reported covered position: Health Policy Advisor, Sen. Finance Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Biosimilars Access and Affordability Act
Client: MERCK & CO., INC · Firm: TIBER CREEK GROUP
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026; Issues related to H.R. 10628/S.5571 - Biosimilars Access and Affordability Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UNITED THERAPEUTICS CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to organs and xenotransplantation.
Filing targets: HOUSE OF REPRESENTATIVES
PATIENT SQUARE CAPITAL via TIBER CREEK GROUP
2026 · third_quarter · Q3
Source: Senate LDA
| THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) | 43 | 2016–2026 |
| PHRMA | 30 | 2011–2017 |
| ACCENTURE | 29 | 2011–2018 |
| ASSOCIATION FOR CLINICAL ONCOLOGY | 28 | 2020–2026 |
| ACADEMY OF MANAGED CARE PHARMACY | 25 | 2021–2026 |
| CAPG | 25 | 2014–2019 |
| FAIR ISAAC CORPORATION (FICO) | 25 | 2011–2017 |
| ACADIA PHARMACEUTICALS INC | 24 | 2020–2026 |
| CIGNA CORPORATION AND SUBSIDIARIES | 23 | 2021–2026 |
| BAY BRIDGE STRATEGIES, INC. (ON BEHALF OF BIOCRYST PHARMACEUTICALS) | 21 | 2013–2018 |
| DELOITTE LLP | 20 | 2015–2020 |
| MODIVCARE SOLUTIONS, LLC | 18 | 2020–2024 |
| BAY BRIDGE STRATEGIES INC (ON BEHALF OF LUMERIS INC ) | 17 | 2011–2017 |
| LEON MEDICAL CENTER | 17 | 2011–2015 |
| SMITHS GROUP PLC | 17 | 2019–2022 |
| ACCOUNTABLE FOR HEALTH | 16 | 2023–2026 |
| AGILON HEALTH, INC. | 16 | 2023–2026 |
| INFUSYSTEMS HOLDINGS, INC. | 16 | 2019–2022 |
| BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.) | 15 | 2020–2022 |
| NUSANO, INC. | 15 | 2023–2026 |
| ELEVANCE HEALTH, INC. | 12 | 2011–2026 |
| PHLOW CORPORATION | 12 | 2021–2023 |
| WHIRLPOOL CORPORATION | 12 | 2012–2014 |
| ABBVIE, INC. | 11 | 2013–2015 |
| EMD MILLIPORE | 11 | 2020–2022 |
| BIOSCRIP | 10 | 2017–2019 |
| HEALTHSPRING, INC. | 10 | 2011–2013 |
| ROIVANT SCIENCES, INC. | 10 | 2018–2020 |
| NIC INC | 9 | 2019–2020 |
| PREVENT OPIOID ABUSE | 9 | 2020–2021 |
| EVERYTOWN FOR GUN SAFETY ACTION FUND | 8 | 2025–2026 |
| HAZELDEN BETTY FORD FOUNDATION | 8 | 2018–2020 |
| LIFE TECHNOLOGIES CORPORATION | 8 | 2011–2012 |
| SOLVENTUM CORPORATION | 8 | 2025–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. (OBO COMPREHENSIVE HEALTH MANAGEMENT, INC.) | 8 | 2018–2019 |
| HEALTHEQUITY | 7 | 2019–2020 |
| MICRON TECHNOLOGY, INC. | 7 | 2013–2015 |
| AT&T SERVICES, INC. | 6 | 2012–2013 |
| BAY BRIDGE STRATEGIES (ON BEHALF OF KINSA, INC.) | 6 | 2020–2021 |
| BICYCLE HEALTH, INC. | 6 | 2023–2024 |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 6 | 2021–2022 |
| CORROHEALTH, INC. | 6 | 2025–2026 |
| HERTZ CORPORATION, THE | 6 | 2011–2013 |
| ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS | 5 | 2025–2026 |
| American Society of Clinical Oncology, Inc. | 5 | 2019 |
| PATIENT SQUARE CAPITAL | 5 | 2025–2026 |
| THE ICKES & ENRIGHT GROUP, INC. (O/B/O AMALGAMATED TRANSIT UNION, AFL-CIO) | 5 | 2012 |
| UNITED THERAPEUTICS CORPORATION | 5 | 2025–2026 |
| BAY BRIDGE STRATEGIES (ON BEHALF OF OSISOFT) | 4 | 2012 |
| BAY BRIDGE STRATEGIES, INC. (ON BEHALF OF BANNER LIFE SCIENCES) | 4 | 2015–2016 |
| REGIONALCARE HOSPITAL PARTNERS | 4 | 2013–2014 |
| AVENUE SOLUTIONS | 3 | 2020 |
| Agios Pharmaceuticals, Inc. | 3 | 2021 |
| CORTEXYME, INC. | 3 | 2021 |
| ICKES AND ENRIGHT GROUP (OBO PUERTO RICO HEALTHCARE CRISIS COALITION INC ) | 3 | 2015–2016 |
| POTOMAC RESEARCH GROUP | 3 | 2012 |
| UBER TECHNOLOGIES INC. | 3 | 2018–2019 |
| JAZZ PHARMACEUTICALS | 2 | 2019 |
| SECURE IDENTITY, LLC (DBA CLEAR) | 1 | 2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY | 1 | 2020 |
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Saving Our Veterans Lives Act of 2025
Client: EVERYTOWN FOR GUN SAFETY ACTION FUND · Firm: TIBER CREEK GROUP
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Saving Our Veterans Lives Act of 2025
Client: EVERYTOWN FOR GUN SAFETY ACTION FUND · Firm: TIBER CREEK GROUP
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Ensuring Community Access to Pharmacist Services Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: ASSOCIATION FOR CLINICAL ONCOLOGY · Firm: TIBER CREEK GROUP
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 3514/S. 1816 - Improving Seniors Timely Access to Care Act of 2025.
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Protecting Patient Access to Cancer and Complex Therapies Act
Client: MERCK & CO., INC · Firm: TIBER CREEK GROUP
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: MERCK & CO., INC · Firm: TIBER CREEK GROUP
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026; Issues related to H.R. 10628/S.5571 - Biosimilars Access and Affordability Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) · Firm: TIBER CREEK GROUP
Issues related to H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) · Firm: TIBER CREEK GROUP
Issues related to H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) · Firm: TIBER CREEK GROUP
Issues related to H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Client: ACCOUNTABLE FOR HEALTH · Firm: TIBER CREEK GROUP
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP), ACO Reach Program and Comprehensive Kidney Care Contracting demonstration program; Issues related to physician reimbursement, including reforms to the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Client: ACCOUNTABLE FOR HEALTH · Firm: TIBER CREEK GROUP
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP), ACO Reach Program and Comprehensive Kidney Care Contracting demonstration program; Issues related to physician reimbursement, including reforms to the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Client: AGILON HEALTH, INC. · Firm: TIBER CREEK GROUP
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the LEAD Model; Issues related to H.R. 9693 - Patients First Act of 2026, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Client: AGILON HEALTH, INC. · Firm: TIBER CREEK GROUP
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the ACO REACH Model; Issues related to the LEAD Model; Issues related to MA data sharing; Issues related to physician reimbursement and MACRA-related policies, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
National Defense Authorization Act for Fiscal Year 2027
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
National Defense Authorization Act for Fiscal Year 2027
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026; Issues related to H.R. 10628/S.5571 - Biosimilars Access and Affordability Act.
Energy and Water Development and Related Agencies Appropriations Act, 2027
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Energy and Water Development and Related Agencies Appropriations Act, 2027
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the LEAD Model; Issues related to H.R. 9693 - Patients First Act of 2026, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Improving Seniors’ Timely Access to Care Act of 2025
Client: ASSOCIATION FOR CLINICAL ONCOLOGY · Firm: TIBER CREEK GROUP
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 3514/S. 1816 - Improving Seniors Timely Access to Care Act of 2025.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Patients Deserve Price Tags Act
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Equitable Community Access to Pharmacist Services Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Health Information Privacy Reform Act
Client: ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS · Firm: TIBER CREEK GROUP
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Health Information Privacy Reform Act
Client: ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS · Firm: TIBER CREEK GROUP
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Health Information Privacy Reform Act
Client: ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS · Firm: TIBER CREEK GROUP
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
National Defense Authorization Act for Fiscal Year 2027
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
National Defense Authorization Act for Fiscal Year 2027
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Saving Our Veterans Lives Act of 2025
Client: EVERYTOWN FOR GUN SAFETY ACTION FUND · Firm: TIBER CREEK GROUP
Issues related to S. 926 - Saving Our Veterans Lives Act of 2025.
Saving Our Veterans Lives Act of 2025
Client: EVERYTOWN FOR GUN SAFETY ACTION FUND · Firm: TIBER CREEK GROUP
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Saving Our Veterans Lives Act of 2025
Client: EVERYTOWN FOR GUN SAFETY ACTION FUND · Firm: TIBER CREEK GROUP
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Chinese Military and Surveillance Company Sanctions Act of 2024
Client: MERCK & CO., INC · Firm: TIBER CREEK GROUP
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026; Issues related to H.R. 10628/S.5571 - Biosimilars Access and Affordability Act.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: ASSOCIATION FOR CLINICAL ONCOLOGY · Firm: TIBER CREEK GROUP
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to H.Con.Res. 14.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) · Firm: TIBER CREEK GROUP
Issues related to hospital and physician reimbursement; Issues related to the hospital industry; Issues related to H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.Con.Res. 14.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 5371 - Continuing Appropriations and Extensions Act, 2026.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: ASSOCIATION FOR CLINICAL ONCOLOGY · Firm: TIBER CREEK GROUP
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 5371 - Continuing Appropriations and Extensions Act, 2026
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 5371 - Continuing Appropriations and Extensions Act, 2026.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) · Firm: TIBER CREEK GROUP
Issues related to hospital and physician reimbursement; Issues related to the hospital industry; Issues related to H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890 - Resident Physician Shortage Reduction Act of 2025; Issues related to H.Con.Res. 14 -Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: ASSOCIATION FOR CLINICAL ONCOLOGY · Firm: TIBER CREEK GROUP
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.Con.Res. 14.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890 - Resident Physician Shortage Reduction Act of 2025; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act; Issues related to Medicaid changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing reforms.
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act; Issues related to Medicaid changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing reforms.
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act.
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS, INC. · Firm: TIBER CREEK GROUP
Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act. Issues related to Medicaid changes in the One Big Beautiful Bill Act (PL 119-21).
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R.1672 - Maintaining Investments in New Innovation Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R.1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); H.R. 1672 - Maintaining Investments in New Innovation (MINI) Act.
Health Care Affordability Act of 2025
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Issues related to proposals impacting employer-sponsored insurance; Issues related to pharmacy and prescription drug pricing policy; Issues related to H.R. 247/S. 846 - Health Care Affordability Act of 2025; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169).
Health Care Affordability Act of 2025
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to insurance coverage, ACA market reforms, and telemedicine flexibilities; Issues related to H.R. 247/S. 46 - Health Care Affordability Act of 2025; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs).
Medicare Enrollment Protection Act of 2025
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to Medicare Enrollment and COBRA Continuation Coverage in H.R. 2744 - the Medicare Enrollment Protection Act of 2025.
Medicare Enrollment Protection Act of 2025
Client: NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) · Firm: TIBER CREEK GROUP
Issues related to Medicare Enrollment and COBRA Continuation Coverage in H.R. 2744 - the Medicare Enrollment Protection Act.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
Access to Prescription Digital Therapeutics Act of 2025
Client: ACADEMY OF MANAGED CARE PHARMACY · Firm: TIBER CREEK GROUP
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: CIGNA CORPORATION AND SUBSIDIARIES · Firm: TIBER CREEK GROUP
Pharmacy issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Pharmacy issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.
Issues related to telemedicine and the rural health transformation fund.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to brokers and the Medicare program.
Issues related to insurance coverage, ACA market reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to gun safety.
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to the Medicare Advantage and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORROHEALTH, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.
Issues related to pharmacy and prescription drug pricing; Issues relating to implementation of the No Surprises Act (PL 116-260); Issues related to price transparency.
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
AGILON HEALTH, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the LEAD Model; Issues related to H.R. 9693 - Patients First Act of 2026, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR CLINICAL ONCOLOGY via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP), ACO Reach Program and Comprehensive Kidney Care Contracting demonstration program; Issues related to physician reimbursement, including reforms to the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to drug pricing; Issues related to the Inflation Reduction Act (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to tariff policy and supply chain policy.
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO., INC via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to intellectual property protections.
Issues related to immunization policy.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026; Issues related to H.R. 10628/S.5571 - Biosimilars Access and Affordability Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHPARTNERS via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to the health insurance and hospital industry; Issues related to telehealth; Issues related to Medicare Advantage; Issues related to ACA Tax Credits.
Issues related to research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to provider reimbursement.
Issues related to H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act.
Issues related to FEMA disaster relief funding.
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to drug pricing; Issues related to the Inflation Reduction Act (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED THERAPEUTICS CORPORATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to organs and xenotransplantation.
Filing targets: HOUSE OF REPRESENTATIVES
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025; Issues related to H.R. 7871/S. 1637 - MVP Act; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act; Issues related to H.R. 3164 - Ensuring Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT SQUARE CAPITAL via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to telemedicine and the rural health transformation fund.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to brokers and the Medicare program.
Issues related to insurance coverage, ACA market reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to gun safety.
Issues related to H.R. 1987/S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to the Medicare Advantage and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR CLINICAL ONCOLOGY via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 3514/S. 1816 - Improving Seniors Timely Access to Care Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORROHEALTH, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to pharmacy and prescription drug pricing; Issues relating to implementation of the No Surprises Act (PL 116-260); Issues related to price transparency.
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
AGILON HEALTH, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Issues related to Medicare Shared Savings Program (MSSP); Issues related to the ACO REACH Model; Issues related to the LEAD Model; Issues related to MA data sharing; Issues related to physician reimbursement and MACRA-related policies, including APM bonus payments; Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program; Issues related to CMS innovation and payment model activities through CMMI.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP), ACO Reach Program and Comprehensive Kidney Care Contracting demonstration program; Issues related to physician reimbursement, including reforms to the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to H.R. 8129 - To amend title XVIII of the Social Security Act to establish a full risk ACO program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO., INC via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to H.R. 8857 - Next GEN Act of 2026.
Issues related to immunization policy.
Issues related to intellectual property protections.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
HEALTHPARTNERS via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to the health insurance and hospital industry; Issues related to telehealth; Issues related to Medicare Advantage; Issues related to ACA Tax Credits.
Issues related to research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to provider reimbursement.
Issues related to hospital and physician reimbursement; Issues related to the hospital industry; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act.
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to tariff policy and supply chain policy.
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Issues related to tariff policy and supply chain policy.
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to pharmacy and prescription drug pricing; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169); Issues relating to implementation of the No Surprises Act (PL 116-260).
Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
UNITED THERAPEUTICS CORPORATION via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to regulatory matters impacting prescription drugs.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PATIENT SQUARE CAPITAL via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to telemedicine and the rural health transformation fund.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to insurance coverage, ACA market reforms, and telemedicine flexibilities; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs); Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to gun safety.
Issues related to S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to the Medicare Advantage and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORROHEALTH, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act; Issues related to the Health Insurance Portability and Accountability Act (HIPAA) (PL 104-191) Privacy Rule: Changes to Support Coordinated Care and Individual Engagement and Reduce Regulatory Burdens.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to provider reimbursement.
Issues related to FEMA disaster relief funding.
Issues related to H.R. 7961 - H-1Bs for Physicians and the Healthcare Workforce Act.
HEALTHPARTNERS via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to research funding.
Issues related to the health insurance and hospital industry; Issues related to telehealth; Issues related to Medicare Advantage; Issues related to ACA Tax Credits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AGILON HEALTH, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP) and the ACO Reach Program; Issues related to Medicare Advantage; Issues related to the extension of Alternative Payment Model bonus payments and physician reimbursement, including the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10) and the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to Medicare payment demonstration projects.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to value-based health care; Issues related to reforming provider payments and the adoption of accountable care; Issues related to Medicare payment demonstration projects; Issues related to reforming payments for skin substitute treatments in the Calendar Year 2026 Medicare Physician Fee Schedule Rule; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to rare disease treatments, including rare disease research incentives; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to drug pricing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SECURE IDENTITY, LLC (DBA CLEAR) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to data privacy and biometric verification.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation, Dept of (DOT)
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR CLINICAL ONCOLOGY via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025. Issues related to H.R. 7871/S. 1637 - MVP Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to tariff policy and supply chain policy.
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
UNITED THERAPEUTICS CORPORATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to USPS zip code changes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PATIENT SQUARE CAPITAL via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to telemedicine and the rural health transformation fund.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to insurance coverage, ACA market reforms, and telemedicine flexibilities; Issues related to H.R. 247/S. 46 - Health Care Affordability Act of 2025; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs).
Issues related to broker compensation in Medicare Advantage.
Issues related to health savings accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to gun safety.
Issues related to gun safety and funding for ATF.
Issues related to gun safety and tax incentives for secure storage.
ELEVANCE HEALTH, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to the Medicare Advantage and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORROHEALTH, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy; Issues related to the continuation of telehealth flexibilities.
Issues related to proposals impacting employer-sponsored insurance; Issues related to pharmacy and prescription drug pricing policy; Issues related to H.R. 247/S. 846 - Health Care Affordability Act of 2025; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169).
Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to protected health information; Issues related to S. 3097 - Health Information Privacy Reform Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AGILON HEALTH, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP) and the ACO Reach Program; Issues related to Medicare Advantage, including S. 1105 - No UPCODE Act; Issues related to the extension of Alternative Payment Model bonus payments and physician reimbursement, including the Medicare Access and CHIP Reauthorization Act of 2015 (PL 114-10); Issues related to the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37), including issues related to the continuation of Medicare telehealth flexibilities; Issues related to Medicare payment demonstration projects.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to value-based health care; Issues related to reforming provider payments and the adoption of accountable care; Issues related to Medicare payment demonstration projects; Issues related to reforming payments for skin substitute treatments in the Calendar Year 2026 Medicare Physician Fee Schedule Rule.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act; Issues related to Medicaid changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to hospital and physician reimbursement; Issues related to the hospital industry; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to provider reimbursement.
Issues related to FEMA disaster relief funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHPARTNERS via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to the health insurance and hospital industry; Issues related to telehealth; Issues related to Medicare Advantage; Issues related to ACA Tax Credits.
Issues related to research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).
ASSOCIATION FOR CLINICAL ONCOLOGY via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (PL 119-37).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR HEALTH INFORMATION OPERATIONS AND STANDARDS via TIBER CREEK GROUP
2025 · fourth_quarter · RR
Issues related to the exchange of healthcare data.
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 5371 - Continuing Appropriations and Extensions Act, 2026.
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 5371 - Continuing Appropriations and Extensions Act, 2026.
ASSOCIATION FOR CLINICAL ONCOLOGY via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to H.Con.Res. 14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 5371 - Continuing Appropriations and Extensions Act, 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLVENTUM CORPORATION via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Issues related to budget reconciliation, appropriations, tax and trade policy; Issues related to Medical Device User Fee Amendments (MDUFA) reauthorization; Issues related to artificial intelligence; Issues related to medical, dental, and health information systems research and development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY OF MANAGED CARE PHARMACY via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICKES & ENRIGHT GROUP (NORTHWELL HEALTH FKA NORTH SHORE-LIJ) via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to hospital and physician reimbursement; Issues related to the hospital industry; Issues related to H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to provider reimbursement.
Issues related to FEMA disaster relief funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHPARTNERS via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to the federal COVID response and its impact on the health insurance and hospital industry; Issues related to telehealth; Issues related to Medicare Advantage; Issues related to ACA Tax Credits.
Issues related to the federal COVID response and its impact on the health insurance and hospital industry.
Issues related to a senior center in Renville County, MN; Issues related to research funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to insurance coverage, ACA market reforms, and telemedicine in the One Big Beautiful Bill Act (PL 119-21).
Issues related to Medicare Enrollment and COBRA Continuation Coverage in H.R. 2744 - the Medicare Enrollment Protection Act of 2025.
Issues related to health savings accounts in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERYTOWN FOR GUN SAFETY ACTION FUND via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to gun safety.
Issues related to gun safety and funding for ATF.
Issues related to gun safety and tax incentives for secure storage; Issues related to tax policy and firearms in the One Big Beautiful Bill Act (PL 119-21).
ELEVANCE HEALTH, INC. via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to the Medicare Advantage and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CORROHEALTH, INC. via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to Medicare Advantage and Medicare Program Integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION AND SUBSIDIARIES via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.
Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability; Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to competition in the health care marketplace.
AGILON HEALTH, INC. via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to value-based health care; Issues related to reforming physician payments and the Medicare Access and CHIP Reauthorization Act (MACRA) (PL 114-10); Issues related to Medicare Advantage; Issues related to the extension of Alternative Payment Model bonus payments; Issues related to Medicare payment demonstration projects; Issues related to physician payment changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to the continuation of Medicare telehealth flexibilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
ACCOUNTABLE FOR HEALTH via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to value-based health care; Issues related to reforming physician payments and the Medicare Access and CHIP Reauthorization Act (MACRA) (PL 114-10); Issues related to Medicare payment demonstration projects; Issues related to physician payment changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to Medicare program integrity initiatives.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS, INC. via TIBER CREEK GROUP
2025 · third_quarter · Q3
Issues related to rare disease treatments, including rare disease research incentives; Issues related to H.R. 1262/S. 932 - Give Kids a Chance Act; Issues related to Medicaid changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to drug pricing reforms.
Issues related to the orphan drug tax credit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED THERAPEUTICS CORPORATION via TIBER CREEK GROUP
2025 · third_quarter · RR
Issues related to pharmaceuticals and organ transplantation.
CORROHEALTH, INC. via TIBER CREEK GROUP
2025 · third_quarter · RR
Issues related to Medicare Advantage.
Issues related to Medicare Advantage.
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R.1672 - Maintaining Investments in New Innovation Act.
Issues related to PBM reform; Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General Intellectual property issues; Issues related to pharmacy benefit managers.
HEALTHPARTNERS via TIBER CREEK GROUP
2025 · second_quarter · Q2
Issues related to the federal COVID response and its impact on the health insurance and hospital industry; Issues related to telehealth; Issues related to Medicare Advantage; Issues related to CMS Health Equity Index; Issues related to ACA Tax Credits.
Issues related to the federal COVID response and its impact on the health insurance and hospital industry.
Issues related to a senior center in Renville County, MN.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pharmacy issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to hospital and physician reimbursement; Issues related to the hospital industry; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues related to FEMA disaster relief funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to hospital and physician reimbursement; Issues related to the hospital industry; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to S. 926 - Saving Our Veterans Lives Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pharmacy issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Pharmacy issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tariff policy and supply chain policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to tariff policy and supply chain policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE